Exosomes Market Segmentation:
Indication
The cancer segment in the exosomes market is expected to hold the largest share of about 72% during the forecast period. The growth of the segment is due to the wide range of uses of exosomes in the identification, assessment, and management of cancer. Exosomes have the potential to be highly effective therapeutic delivery vehicles for proteins, small chemicals, and RNAs intended to specifically target cancer cells. Furthermore, exosome-borne lipids, proteins, and nucleic acids are being investigated as potential targets for cancer therapy and as promising biomarkers for cancer prognosis and detection. The industry is anticipated to grow in the near future because of the rising incidence of cancer and the growing need for early disease detection. In 2020, there were projected to be 18.1 million cases of cancer worldwide. Men accounted for 9.3 million of these instances, while women made for 8.8 million.
Application
Exosomes market from the therapeutic segment is anticipated to hold largest revenue share of about 67% during the forecast period. It is possible to use exosomes as a treatment platform for COVID-19 and other disorders. Exosomes can be used in clinical settings as cell-free substitutes to treat a variety of illnesses and promote tissue regeneration since they can carry therapeutic cargo components without causing cellular toxicity or immunological rejection. Furthermore, exosomes produced from stem cells have the benefit of utilizing the regenerative and anti-inflammatory properties of their parent cells; as a result, exosome therapy can be developed to treat respiratory viral illnesses like SARS-CoV-2. Given their natural material transportation qualities, capacity to sustain intrinsic long-term circulation, and high biocompatibility—all of which make them ideal for the delivery of a wide range of proteins, chemicals, and nucleic acids—exosomes hold great promise as a drug delivery vehicle.
Our in-depth analysis of the global exosomes market includes the following segments:
|
Product & Services |
|
|
Indication |
|
|
Work Flow |
|
|
Application |
|
|
Manufacturing Services |
|
|
End-User |
|
